Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine: for the prevention of genital warts in males

KP Garnock-Jones, AR Giuliano - Drugs, 2011 - Springer
Abstract The quadrivalent HPV types 6, 11, 16, 18 vaccine (Gardasil®) is a recombinant
vaccine comprising purified virus-like particles derived from the L1 capsid proteins of HPV …

Low-risk Human Papillomavirus: Genital Warts, Cancer and Respiratory Papillomatosis

CJN Lacey, N Guimera, SM Garland - Human Papillomavirus, 2020 - Elsevier
Genital warts (GW) are a common sexually transmitted disease in young people usually
caused by HPV 6 or HPV 11. GW are a significant public health problem worldwide …

Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact

JML Brotherton, DM Gertig - Expert review of anti-infective therapy, 2011 - Taylor & Francis
Of the 40 types of human papillomavirus that can infect the mucosal epithelium, four types
can now be prevented using prophylactic vaccination. Two of these types (high-risk types 16 …

Evaluating the epidemiology and morbidity burden associated with human papillomavirus in Israel: accounting for CIN1 and genital warts in addition to CIN2/3 and …

O Shavit, R Raz, M Stein, G Chodick, E Schejter… - … health economics and …, 2012 - Springer
Background Human papillomavirus (HPV) infection is mostly associated with cervical cancer
(CC). However, it can cause other illnesses as well, all of which impact on people's …

The costs of managing genital warts in the UK by devolved nation: England, Scotland, Wales and Northern Ireland

VAH Coles, R Chapman, T Lanitis… - … journal of STD & …, 2016 - journals.sagepub.com
Genital warts, 90% of which are caused by human papillomavirus types 6 and 11, are a
significant problem in the UK. The cost of managing genital warts was previously estimated …

[HTML][HTML] Formaldehyde 5% in Flexible Collodion Compared to Cryotherapy for Treatment of Female Genital Warts: A Randomized Clinical Trial

BN Jahromi, M Razeghi, L Dastgheib… - Indian Journal of …, 2022 - journals.lww.com
Objectives: Genital wart is a sexually transmitted disease caused by human papillomavirus
(HPV) and is responsible for discomfort, and decreased quality of life and productivity in …

[HTML][HTML] Optimal prophylactic vaccination in segregated populations: When can we improve on the equalising strategy?

MJ Keeling, JV Ross - Epidemics, 2015 - Elsevier
One of the fundamental problems in public health is how to allocate a limited set of
resources to have the greatest benefit on the health of the population. This often leads to …

HPV 感染对女性心理健康影响的研究进展

林川, 杨君, 李成志 - 重庆医学, 2013 - cqvip.com
HPV感染对女性心理健康影响的研究进展-[维普官方网站]-www.cqvip.com-维普网  我的维普
购物车 充值 客服 首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线分享 | 学者 …

Cost–effectiveness of catch-up programs in human papillomavirus vaccination

MA De Peuter, KJ Littlewood, L Annemans… - Expert Review of …, 2010 - Taylor & Francis
We reviewed cost–effectiveness models that combine routine vaccination with the human
papillomavirus (HPV) vaccine with temporary catch-up programs. Cost–effectiveness results …

Implementation of prophylactic HPV vaccination: progress and future challenges

L Brabin, HC Kitchener, PL Stern - Expert Review of Obstetrics & …, 2010 - Taylor & Francis
Two licensed vaccines designed to prevent certain human papillomavirus (HPV) infections
are currently available. Their use to prevent cervical cancer has depended on data from …